San Antonio Tech Event→
Founder and Managing Partner, Frazier Healthcare Ventures
Managing Director of Hatteras Discovery and Venture Partner at Hatteras Venture Partners
CEO of Dynamis Corporation
Managing director, the Foundry Group
CEO and Co-Founder, Tamr
Co-Founder and CEO, DNAnexus
President & CEO, Indiana Biosciences Research Institute
Professor, Michigan State University
February 20, 2018 ·
June 14, 2018 ·
NKT Therapeutics is developing drugs that target a class of immune cells known as natural killer T cells.
From Our Editors · Video
David Edwards, professor at Harvard University, on the future of food: video interview
Lita Nelsen recently retired as the long-time director of MIT’s Technology Licensing Office.
Xconomy Insight · Special Report
Success or failure depends on you. Get advice from the experts to help your startup succeed
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.
© 2007-2018, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.